cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Celularity Inc
5 own
4 watching
Current Price
$3.17
$-0.14
(-4.23%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
43.68M
52-Week High
52-Week High
8.90000
52-Week Low
52-Week Low
1.59000
Average Volume
Average Volume
0M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization43.68M
icon52-Week High8.90000
icon52-Week Low1.59000
iconAverage Volume0M
iconDividend Yield--
iconP/E Ratio--
What does the Celularity Inc do?
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company s lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase 1 clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase 1 clinical trial to treat acute myeloid leukemia, as well as in Phase 1/2a clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase 1 clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn's disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.
Read More
How much money does Celularity Inc make?
News & Events about Celularity Inc.
Globe Newswire
10 months ago
SAN DIEGO, June 24, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"): Faraday Future Intelligent Electric Inc. f/k/a Property Solutions Acquisition ...
Globe Newswire
11 months ago
In patients with relapsed refractory acute myeloid leukemia (R/R AML) treated with a four-dose regimen consisting of 1.8 billion CYNK-001 cells per dose, two of four patients achieved an objective response at Day 28 In patients with measurable residual disease-positive (MRD positive) AML treated ...
Globe Newswire
1 year ago
Hariri, Celularitys CEO, Chairman and Founder, will open the meeting with the keynote address highlighting recent progress and important next steps for the science of longevity together with Scott Gottlieb, M.D., Senior Fellow of the American Enterprise Institute andformer Commissioner of the U.S. ...
Globe Newswire
1 year ago
FLORHAM PARK, N.J., April 05, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, today announced that it has entered into a definitive agreement with a single, healthcare-...
Globe Newswire
1 year ago
FLORHAM PARK, N.J., April 04, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, announced today an oral and poster presentation at the upcoming 2023 Annual Meeting Society for...
Frequently Asked Questions
Frequently Asked Questions
What is Celularity Inc share price today?
plus_minus_icon
Can Indians buy Celularity Inc shares?
plus_minus_icon
How can I buy Celularity Inc shares from India?
plus_minus_icon
Can Fractional shares of Celularity Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Celularity Inc stocks?
plus_minus_icon
What is today’s traded volume of Celularity Inc?
plus_minus_icon
What is today’s market capitalisation of Celularity Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Celularity Inc?
plus_minus_icon
What percentage is Celularity Inc down from its 52-Week High?
plus_minus_icon
What percentage is Celularity Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.17
$-0.14
(-4.23%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00